These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
381 related articles for article (PubMed ID: 19801040)
1. Evaluation of the effects of PM101, a cyclodextrin-based formulation of intravenous amiodarone, on blood pressure in healthy humans. Cushing DJ; Adams MP; Cooper WD; Zhang B; Lipicky RJ; Kowey PR Am J Cardiol; 2009 Oct; 104(8):1152-7. PubMed ID: 19801040 [TBL] [Abstract][Full Text] [Related]
2. PM101: a cyclodextrin-based intravenous formulation of amiodarone devoid of adverse hemodynamic effects. Cushing DJ; Kowey PR; Cooper WD; Massey BW; Gralinski MR; Lipicky RJ Eur J Pharmacol; 2009 Apr; 607(1-3):167-72. PubMed ID: 19232340 [TBL] [Abstract][Full Text] [Related]
3. Comparison of the cardiac electrophysiology and general toxicology of two formulations of intravenous amiodarone in dogs. Cushing DJ; Cooper WD; Gralinski MR; Lipicky RJ; Kudenchuk PJ; Kowey PR Cardiovasc Toxicol; 2009 Sep; 9(3):126-33. PubMed ID: 19554478 [TBL] [Abstract][Full Text] [Related]
4. The hypotensive effect of intravenous amiodarone is sustained throughout the maintenance infusion period. Cushing DJ; Cooper WD; Gralinski MR; Lipicky RJ Clin Exp Pharmacol Physiol; 2010 Mar; 37(3):358-61. PubMed ID: 19793107 [TBL] [Abstract][Full Text] [Related]
5. PM101: intravenous amiodarone formulation changes can improve medication safety. Souney PF; Cooper WD; Cushing DJ Expert Opin Drug Saf; 2010 Mar; 9(2):319-33. PubMed ID: 20074019 [TBL] [Abstract][Full Text] [Related]
6. Intravenous amiodarone for incessant tachyarrhythmias in children: a randomized, double-blind, antiarrhythmic drug trial. Saul JP; Scott WA; Brown S; Marantz P; Acevedo V; Etheridge SP; Perry JC; Triedman JK; Burriss SW; Cargo P; Graepel J; Koskelo EK; Wang R; Circulation; 2005 Nov; 112(22):3470-7. PubMed ID: 16316969 [TBL] [Abstract][Full Text] [Related]
7. Lack of a hypotensive effect with rapid administration of a new aqueous formulation of intravenous amiodarone. Somberg JC; Timar S; Bailin SJ; Lakatos F; Haffajee CI; Tarjan J; Paladino WP; Sarosi I; Kerin NZ; Borbola J; Bridges DE; Molnar J; Am J Cardiol; 2004 Mar; 93(5):576-81. PubMed ID: 14996582 [TBL] [Abstract][Full Text] [Related]
9. Practical regimen for amiodarone use in preventing postoperative atrial fibrillation. Zebis LR; Christensen TD; Thomsen HF; Mikkelsen MM; Folkersen L; Sørensen HT; Hjortdal VE Ann Thorac Surg; 2007 Apr; 83(4):1326-31. PubMed ID: 17383335 [TBL] [Abstract][Full Text] [Related]
10. A randomized comparison of amiodarone and class IC antiarrhythmic drugs to treat atrial fibrillation in patients paced for sinus node disease: the Prevention Investigation and Treatment: A Group for Observation and Research on Atrial arrhythmias (PITAGORA) trial. Gulizia M; Mangiameli S; Orazi S; Chiarandà G; Piccione G; Di Giovanni N; Colletti A; Pensabene O; Lisi F; Vasquez L; Grammatico A; Boriani G; Am Heart J; 2008 Jan; 155(1):100-7, 107.e1. PubMed ID: 18082498 [TBL] [Abstract][Full Text] [Related]
11. Computerized M-mode echocardiography in the assessment of cardiovascular effects during intravenous administration of amiodarone. Cinelli P; Romano S; Castaldo G; de Scalzi M; Citi S; de Leonardis V Methods Find Exp Clin Pharmacol; 1984 Jan; 6(1):27-32. PubMed ID: 6717168 [TBL] [Abstract][Full Text] [Related]
12. Effects of a high dose intravenous bolus amiodarone in patients with atrial fibrillation and a rapid ventricular rate. Hofmann R; Steinwender C; Kammler J; Kypta A; Leisch F Int J Cardiol; 2006 Jun; 110(1):27-32. PubMed ID: 16046015 [TBL] [Abstract][Full Text] [Related]
13. Comparative study of intravenous amiodarone and procainamide in the treatment of atrial fibrillation of recent onset. Xanthos T; Prapa V; Papadimitriou D; Papadimitriou L Minerva Cardioangiol; 2007 Aug; 55(4):433-41. PubMed ID: 17653020 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of two formulations of ramipril in Korean adults with mild to moderate essential hypertension: an 8-week, multicenter, prospective, randomized, open-label, parallel-group noninferiority trial. Kim SH; Chung WY; Zo JH; Kim MA; Chang HJ; Cho YS; Youn TJ; Chae IH; Choi DJ; Gwak JJ; Lee HY; Park JS; Kang HJ; Kim YJ; Kim HS Clin Ther; 2009 May; 31(5):988-98. PubMed ID: 19539099 [TBL] [Abstract][Full Text] [Related]
15. Safety of hydroxocobalamin in healthy volunteers in a randomized, placebo-controlled study. Uhl W; Nolting A; Golor G; Rost KL; Kovar A Clin Toxicol (Phila); 2006; 44 Suppl 1():17-28. PubMed ID: 16990190 [TBL] [Abstract][Full Text] [Related]
16. A randomized, double-blind, placebo-controlled study of the effect of sustained-release bupropion on blood pressure in individuals with mild untreated hypertension. Thase ME; Haight BR; Johnson MC; Hunt T; Krishen A; Fleck RJ; Modell JG J Clin Psychopharmacol; 2008 Jun; 28(3):302-7. PubMed ID: 18480687 [TBL] [Abstract][Full Text] [Related]